Suscribirse

Titanium-titanium modular neck for primary THA. Result of a prospective series of 170 cemented THA with a minimum follow-up of 5 years - 01/04/15

Doi : 10.1016/j.otsr.2014.12.013 
M. Ollivier, S. Parratte , A. Galland, A. Lunebourg, X. Flecher, J.-N. Argenson
 Institut du mouvement et de l’appareil locomoteur, UMR CNRS 787/AMU, hôpital Sainte-Marguerite, centre hospitalo-universitaire Sud, boulevard de Sainte-Marguerite, 13009 Marseille, France 

Corresponding author. Service de chirurgie orthopédique, institut du mouvement et de l’appareil locomoteur, UMR CNRS 787/AMU, hôpital Sainte-Marguerite, centre hospitalo-universitaire Sud, boulevard de Sainte-Marguerite, 13009 Marseille, France. Tel.: +33 4 91 74 50 11; fax: +33 4 91 74 56 25.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Although they have been in use since the end of the 1980s, modular titanium neck components are associated with a risk of wear or fracture, and their safety has recently become a subject of debate and has never been evaluated in a consecutive series of patients. The goal of this study was to evaluate: revision-free survival of these implants after a minimum follow-up of 5 years; clinical and radiographic results; and the potential complications associated with the use of modular titanium neck components.

Hypothesis

The use of titanium modular neck on cemented titanium THA is safe at a minimum follow-up of 5 years.

Patients and methods

Between January 2006 and December 2008, we prospectively followed 170 patients (170 hips) who underwent primary anatomical THA with a modular cemented titanium stem design implant. The indications were unilateral THA for primary (n=160) or secondary (n=10) hip osteoarthritis (aseptic osteonecrosis of the femoral head or hip dysplasia). Mean age of patients was 75.4±5.8 years old (52–85), and mean BMI was 26.1±4.5kg/m2 (16.6–42.1). Patients were operated on by a modified Watson-Jones anterolateral approach based on preoperative 2D planning. All patients underwent annual clinical and radiological follow-up by an independent observer.

Results

At a mean follow-up of 71±8 months (60–84), 5 patients died and 7 were lost to follow-up. There was no revision of THA after a maximum follow-up of 84 months. The Harris score improved significantly from 50.4±11.3 (0–76) preoperatively to 84.5±15.2 (14–100) at the final follow-up. There was no difference in postoperative femoral offset or the position of the center of rotation compared to the opposite side. On the other hand, the neck-shaft angle (NSA) and limb length were corrected (2±5° [−11 to +14°] and 2.16±3.6mm [−7.4 to +12.7mm]) respectively. Fifteen patients (9%) had limb length discrepancies of more than 5mm and 4 patients (2%) of more than 10mm. There were no complications due to the modular implant design.

Discussion

Our study suggests that the use of cemented titanium implants with a modular titanium stem is safe at a follow-up of 5 years. The modular design does not prevent limb length discrepancies but restores femoral offset.

Level of evidence

IV: prospective, non-comparative study.

El texto completo de este artículo está disponible en PDF.

Keywords : Total hip replacement, Hip anatomy, Modular neck, Cemented stem


Esquema


© 2015  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 101 - N° 2

P. 137-142 - avril 2015 Regresar al número
Artículo precedente Artículo precedente
  • Oral information in orthopaedics: How should the patient's understanding be assessed?
  • K. Giudici, P. Gillois, H. Coudane, F. Claudot
| Artículo siguiente Artículo siguiente
  • The Asia proximal femoral nail antirotation versus the standard proximal femoral antirotation nail for unstable intertrochanteric fractures in elderly Chinese patients
  • J. Li, L. Cheng, J. Jing

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.